In tumors with intact p53, autophagy inhibition resulted in decreased metabolism activity, whereas in tumors with loss of p53 function (embryonic homozygous TP53 deletion), it induced an increase in glucose consumption for anabolic pathway activity, fueling cancer cell proliferation. Here, TP53 is linked to cancer.